Target intelligence / Profile preview

Membrane protein (SARS-CoV-2) (M protein)

Target
M protein
Molecular classification
Viral structural protein, Membrane protein, Viroporin (putative)
01

Overview

The Membrane (M) protein of SARS-CoV-2 is the most abundant structural protein of the virus and serves as the central coordinator of viral assembly and morphogenesis. It is a triple-spanning transmembrane protein that interacts with other structural components, including the Spike (S), Envelope (E), and Nucleocapsid (N) proteins, to drive the formation of the viral envelope and the budding of new virions from the host cell's endoplasmic reticulum-Golgi intermediate compartment (ERGIC). Beyond its structural role, the M protein contributes to viral pathogenesis by suppressing the host's innate immune response, specifically by inhibiting the induction of type I and III interferons through interference with the MAVS and TBK1 signaling pathways. Recent breakthroughs have identified the M protein as a viable therapeutic target for small-molecule inhibitors, such as JNJ-9676 and CIM-834, which disrupt the critical conformational transition between its 'short' and 'long' states required for viral assembly. These inhibitors demonstrate potent, broad-spectrum antiviral activity against various sarbecoviruses, offering a novel strategy to combat COVID-19 and potentially future coronavirus outbreaks.

Other names
Membrane proteinM proteinMatrix proteinStructural protein M
02

Mechanism of action

Inhibition of viral assembly by blocking the conformational switch from the short (Mshort) to the long (Mlong) state, thereby preventing virion maturation and release.

03

Biological functions

Viral assemblyMorphogenesisMembrane curvature inductionImmune evasionInterferon signaling inhibitionProtein-protein interaction
04

Disease associations

InfectionCOVID-19Severe acute respiratory syndrome
05

Safety considerations

Emergence of drug resistance through mutations in the M protein transmembrane domainPotential for off-target effects on host membrane trafficking pathwaysBreadth of activity across diverse coronavirus variants
06

Interacting drugs

JNJ-9676

1 more in the full profile.

07

Biomarkers

Viral RNA loadM-protein-specific CD4+ T cell responseViral particle titers

Beyond the preview

Go deeper on Membrane protein (SARS-CoV-2) (M protein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Membrane protein (SARS-CoV-2) (M protein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call